REPORT COPYRIGHT VIOLATION IN REPLY
|
Message Subject
|
>>>EBOLA 2014-15 >> Latest News and Updates for MERS, Ebola and other spreading nasties<<<
|
Poster Handle
|
frostback |
Post Content
|
Excellent a who's who of the players in the EBOLA industry coincidence ? Here are some snippets and links for a little light reading about TEKMIRA Tekmira's Chief Technical Officer, Dr. Ian MacLachlan, presented new preclinical data showing 100% survival was achieved when dosing with TKM-Marburg at 0.5 mg/kg began 72 hours after infection with otherwise lethal quantities of the Marburg virus. Dosing then continued once daily for seven days. Earlier data from this collaborative research between Tekmira and the University of Texas Medical Branch (UTMB) showed 100% survival was achieved when dosing at 0.5 mg/kg TKM-Marburg began either one hour, 24 hours, or 48 hours after infection with otherwise lethal quantities of the virus. These studies represent the first known demonstration of protection of non-human primates from Marburg-Angola, the most lethal strain of Marburg virus. I [ link to investor.tekmirapharm.com] February 2014, UTMB and Tekmira, along with other collaborators, were awarded additional funding from the National Institutes of Health (NIH) in support of this research. [ link to investor.tekmirapharm.com] Link to other press releases : [ link to investor.tekmirapharm.com] Interesting timing ! Quoting: frostback he was also a speaker at a medical workshop held last august (2013) - full agenda at link as well as all of the sponsors for the event [ link to respond.niaid.nih.gov (secure)] Quoting: ladyannie2009
|
|
Please verify you're human:
|
|
Reason for copyright violation:
|